112 related articles for article (PubMed ID: 32018254)
1. Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma.
Liu X; Wang Y; Guo Q; Luo H; Luo Q; Li Q; Wu Z; Jin F
Oncol Res Treat; 2020; 43(4):140-145. PubMed ID: 32018254
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma.
Liu X; Huang E; Wang Y; He Y; Luo H; Zhong M; Qiu D; Li C; Yang H; He G; Zhou J; Jin F
Radiat Oncol; 2017 Apr; 12(1):76. PubMed ID: 28449713
[TBL] [Abstract][Full Text] [Related]
3. A comparison of volumetric modulated arc therapy and sliding-window intensity-modulated radiotherapy in the treatment of Stage I-II nasal natural killer/T-cell lymphoma.
Liu X; Yang Y; Jin F; He Y; Zhong M; Luo H; Qiu D; Li C; Yang H; He G; Wang Y
Med Dosim; 2016; 41(1):42-6. PubMed ID: 26428072
[TBL] [Abstract][Full Text] [Related]
4. Application of 3D-print silica bolus for nasal NK/T-cell lymphoma radiation therapy.
Dai G; Xu X; Wu X; Lei X; Wei X; Li Z; Xiao Q; Zhong R; Bai S
J Radiat Res; 2020 Nov; 61(6):920-928. PubMed ID: 32960262
[TBL] [Abstract][Full Text] [Related]
5. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
Taggar AS; Graham D; Kurien E; Gräfe JL
J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585
[TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
[TBL] [Abstract][Full Text] [Related]
8. Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma.
Wang H; Li YX; Wang WH; Jin J; Dai JR; Wang SL; Liu YP; Song YW; Wang ZY; Liu QF; Fang H; Qi SN; Liu XF; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1115-21. PubMed ID: 21514070
[TBL] [Abstract][Full Text] [Related]
9. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
10. A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma.
Tomita N; Kodaira T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A
Br J Radiol; 2009 Aug; 82(981):756-63. PubMed ID: 19366734
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of skin toxicity in patients with extranodal nasal-type natural killer/T-cell lymphoma after treatment with intensity-modulated radiotherapy and conventional radiotherapy.
Gu Y; Yu H; Zuo X; Cao Q; Liang T; Ren Y; Yang H; Yang D
J Cancer Res Ther; 2018 Dec; 14(Supplement):S975-S979. PubMed ID: 30539832
[TBL] [Abstract][Full Text] [Related]
12. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
14. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
15.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
16. Sparing of normal tissues with volumetric arc radiation therapy for glioblastoma: single institution clinical experience.
Briere TM; McAleer MF; Levy LB; Yang JN
Radiat Oncol; 2017 May; 12(1):79. PubMed ID: 28464840
[TBL] [Abstract][Full Text] [Related]
17. A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma.
Xu LM; Kang ML; Jiang B; Liu QF; Li YX
Med Dosim; 2018 Spring; 43(1):91-99. PubMed ID: 28935521
[TBL] [Abstract][Full Text] [Related]
18. Estimation of radiotherapy modalities for patients with stage I-II nasal natural killer T-Cell lymphoma.
Liu X; Wu F; Guo Q; Wang Y; He Y; Luo H; Li Q; Zhong M; Li C; Yang H; Zhou J; Jin F
Cancer Manag Res; 2019; 11():7219-7229. PubMed ID: 31534370
[TBL] [Abstract][Full Text] [Related]
19. Volumetric-modulated arc therapy using multicriteria optimization for body and extremity sarcoma.
Young MR; Craft DL; Colbert CM; Remillard K; Vanbenthuysen L; Wang Y
J Appl Clin Med Phys; 2016 Nov; 17(6):283-291. PubMed ID: 27929501
[TBL] [Abstract][Full Text] [Related]
20. Flattening Filter-Free Beams in Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy for Sinonasal Cancer.
Lu JY; Zheng J; Zhang WZ; Huang BT
PLoS One; 2016; 11(1):e0146604. PubMed ID: 26734731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
